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The epidemic of childhood allergic disorders has been associated to the decline of infectious disease. However,
exposure to many triggers (airborne viruses, tobacco smoke, pollution, indoor allergens, etc.) contribute to the
disease. Breast feeding practices, nutrition, dietary and obesity also play a multifaceted role in shaping the observed
worldwide trends of childhood allergies. Guidelines for treatment are available, but their implementation is
suboptimal. Then developed countries are slowing learning integrating the development of suitable guidelines with
implementation plans. Awareness, psychosocial and family factors strongly influence asthma and food allergy control.
Moreover, monitoring tools are necessary to facilitate self-management. By taking into consideration these and many
other pragmatic aspects, national public health programs to control the allergic epidemic have been successful in
reducing its impact and trace the need for future research in the area.
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Asthma and allergic rhinitis levels among children expe-
rienced a boost in the second half of the 20th century
especially [1,2] in developed countries, causing enor-
mous burden for patients and societies [3]. However, the
epidemiological heterogeneity at country level is great.
In Iceland for example, a cohort of 179 children moni-
tored for allergic manifestations for two decades showed
a cumulative prevalence of 29% for asthma during the
study period, with a peak prevalence of 28% at age of
4 years [4]. Similarly, the prevalence of asthma in Irish
schoolchildren, aged 6–9 moved from 21.7% in 2002 to
23.5% in 2007 [5]. By contrast, in Belarus, in a cross-
sectional study conducted in 2010 examined 2606 urban
and 2422 rural children aged 6–16 years, the prevalence
of asthma was as low as 3.84%. Symptoms of hay fever
were also astonishingly rare (2.45%), when compared to
the prevalence registered in the rest of Europe [6]. In
parallel, dramatic increase of food allergies in the recent
15 yrs released a second wave of the allergic epidemic;
however causing factors are still uncertain. In Australia* Correspondence: salvatore.tripodi@gmail.com
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article, unless otherwise stated.for example, 10% of all infants suffer from a confirmed,
IgE-mediated food allergy [7]. Many putative factors
were here nominated, such as increased consumption
(e.g. seafood allergies) [8], progressive urbanization [7],
environmental factors and increased atopic disorders of
the parents [9-11] or the increase in sensitization to
pollen allergens (e.g. profilins, Bet v 1 and other PR-10
molecules, lipid transfer proteins) which cause the oral
allergy syndrome [12]. A recent study on 3800 Finnish
children demonstrated how children of allergic parents
had a 2-fold higher risk to be sensitized/allergic to food
if one and 3-fold risk if both parents suffered from any
allergic manifestation [13]. On individual level, other
factors including severe atopic eczema, maternal anti-
helminthic therapy during pregnancy, birth season and
order were suggested to affect the risk of food allergy
outbreak in childhood [9,14-16]. For example, children
born in autumn/winter had significantly a higher rate of
food allergies compared with children born in spring/
summer according to recent studies on 835 Australian
and 1177 Korean children separately [11,15]. Birth order
was inversely related to the risk of food allergy and
eczema [16].
Although infections are risk factors of chronic urticaria
[17] and other allergic diseases, hygiene and anti-infectiousCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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asthma and allergies and they can act even before birth.
Maternal anti-helminthic therapy, while protecting the
fetus from helminth infection, may facilitate allergy as sug-
gested by a randomized, DBPC study with albendazole on
more than 2500 Ugandan women. In this trial, a positive
relation between mother’s treatment and increased risk for
wheezing and eczema in infancy was found [14]. Gram
negative bacteria have been the first category of infectious
agents believed to protect from asthma and allergies. The
Dutch WHISTLER-birth cohort has recently found that
exposure to endotoxin in the first two months of life, in
combination with house dust mite and cat allergens, is
associated with an increase in the neonatal respiratory
compliance. The authors concluded that endotoxin may
contribute to the development of a normal lung function
and maturity [18]. Not only bacteria, but also some viruses
may protect of atopy. In American children up to 8 yrs of
age, wild-type varicella zoster infection is associated with
less atopic dermatitis (AD) and asthma, a phenomenon
explained by suppression of IgE production and allergic
sensitization and modified leukocyte subsets [19]. Under
the hygiene hypothesis, the so-called “farming effect” is by
far the most investigated epidemiological model. A meta-
analysis of 39 studies showed a 25% lower asthma preva-
lence among subjects exposed to farming environment
compared with unexposed subjects [20]. However, the
basis of a protective effect of farming environment is still
not sufficient understood. As proposed in the late nineties,
a high microbial turnover at mucosal surfaces and a broad
spectrum of microbial contacts in the every-day life may
be at the basis of the atopy protecting effect of a traditional
lifestyle [21,22] also by exerting an influence at the level of
GALT [23,24]. This branch of the hygiene hypothesis,
which may be defined as the “biodiversity” hypothesis, has
been later supported by studies showing that the diversity
of microbial flora early in life is protecting from atopic ec-
zema [25,26] and that the diversity of exposure to bacteria
or fungi is an atopy protecting factor in farming children
[27]. Accordingly, a cross-sectional study of almost 300
German children has shown that the sole ingestion of the
farming milk is linked to less asthma by an increase in
T-regulatory cells levels [28]. Similarly, local and systemic
immune responses of piglets nursed by their mother on a
commercial farm differ from those of isolated piglets fed
with formula in a “clean” environment and display stronger
regulatory components at mucosa level (CD4(+) CD25(+)
Foxp3(+) regulatory T-cell) and higher IgG levels to food
proteins at weaning [29]. A low-grade (or the so-called
“minimal persistent”) inflammation induced by a farming
environment in early childhood may protect against aller-
gic diseases. In 653 children from the PASTURE birth co-
hort, those with undetectable high sensitive CRP (hsCRP)
had increased prevalence of sensitization to inhaled andseasonal allergens [30]. However, the farming environment
is showing a wheeze-protective effect also independently
from atopy, for example by modifying the susceptibility to
wheeze during viral infections [31].
The role of atopic sensitization and viral infections in
asthma has been extensively reviewed [32] and investi-
gated [33]. An open question remains the sequential rela-
tionship between these two components. A longitudinal
study on 285 American children with high risk for allergic
diseases and asthma demonstrated that sensitization to
aeroallergens increases the risk of wheezing caused by
HRV (but not by respiratory syncytial virus). In contrast,
viral wheeze did not increase the risk for subsequent aller-
gic sensitization. This study’s conclusion was that allergic
sensitization is the one who precedes and might promote
viral caused wheezing, and not the other way round [34].
However, other infections are also associated with asthma
development. The ISAAC-Phase Two study found that
pertussis and measles are associated with symptoms of
asthma, rhinoconjunctivitis and eczema in schoolchildren
aged 8–12 years, independently from IgE responses [35].
As a part of the same study, an investigation among more
than 23,900 schoolchildren aged 8–12 years showed that
tuberculosis was associated with asthma, hay fever and ec-
zema symptoms, but not to immunization with BCG [36].
In Latin America not only helminthic infections [37] but a
broad set of infections interfere with asthma and its atopic
background. By contrast, in 1128 urban children from
Salvador-Brazil tested to the 8 most common local patho-
gens those with 3 or fewer infection markers showed a
higher prevalence of sIgE and SPT reactivity compared
with those with 4 or more infection markers, but no asso-
ciation of these markers to asthma could be established
[38]. The heterogeneity of the conclusions reached by dif-
ferent studies highlights the need of large international
studies designed to increase sample heterogeneity and
evaluation of local factors to minimize their confounding
influence. Anyhow, early prevention is now necessary to
avoid further progression of the allergy epidemic. There-
fore, screening tests should be optimized to devise appro-
priate and economic national prevention and treatment
strategies [9,39].
Guidelines for treatment are available, but their im-
plementation is suboptimal. Then developed countries
are slowing learning integrating the development of
suitable guidelines with implementation plans. Aware-
ness, psychosocial and family factors strongly influence
asthma and food allergy control. Moreover, monitoring
tools are necessary to facilitate self-management. By
taking into consideration these and many other prag-
matic aspects, national public health programs to con-
trol the allergic epidemic have been successful in
reducing its impact and trace the need for future re-
search in the area.
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Traffic-related air pollution (TRAP) and biomass fuels
(BMF) play a central role in the asthma epidemic espe-
cially in middle and low income countries. In Asia,
TRAP and BMF increase the risk of asthma outbreaks,
asthma exacerbations, respiratory infections and even
COPD [40]. But also in a high income country, such as
Canada, the frequency and duration of asthma exacerba-
tions were associated with the levels of air pollution
[41]. Domestic usage of BMF for fire, especially in low-
income countries, is strongly associated with asthma and
other lower respiratory diseases. Raising awareness at
community level about this problem can reduce the
negative impact caused by BMF [42]. In parallel, cam-
paigns and legislations against tobacco smoke must be
reinforced in high income countries, where this risk fac-
tor has not been yet defeated. Indeed, the ISAAC-Phase
Three study among Maltese children demonstrated that
passive and active tobacco smoke, that still is a frequent
factor in that country, increased the risk of wheezing,
exercise-induced wheezing, asthma, and rhinitis [43].
Furthermore, passive tobacco smoke’s influence is even
stronger when it interacts with other risk factors, such
as atopic sensitization. Among 486 children from the
CCAAPS birth cohort, lung function was impaired at
the ages 2, 4 and 7 years in atopic polysensitized girls ex-
posed to tobacco smoke [44]. The effect of tobacco
smoke seems to be partially affected also by genetic pre-
disposition. Studies in the Norwegian ECA- and GAIN-
cohorts have found that CHRNA3/5 polymorphisms on
chromosome 15 are positively associated with bronchial
hyperresponsiveness, especially in children exposed to
tobacco smoke, no matter if set out in-utero or indoor
at 10 yrs of age [45]. Similarly, among 157 children of
the ECA-birth cohort, the impact of tobacco smoke ex-
posure and pet keeping on allergy was conditioned by a
limitation of CD14 methylation levels in exposed sub-
jects [46]. All these data reinforce the concept that to-
bacco smoke must be contrasted at population level but
also that risk factors of susceptibility must be taken into
account at individual level.
Obesity, physical exercise and nutrition
The asthma epidemic is not the only one among children
of developed and developing countries. A parallel increase
in obesity and asthma rates suggests that allergic respira-
tory disease may be linked to dietary factors and behaviors
and that the two conditions may influence each other [47].
Accordingly, a cross-sectional questionnaire-based survey
in almost 34,700 Japanese children aged 4–5 years demon-
strated how important obesity is in asthma management;
current asthma was significantly more prevalent in over-
weight children compared with underweight and normal
weight children after adjusting for other variables, such asgender, other coexisting allergic diseases, and parental his-
tory of asthma [48]. Weight reduction has been associated
with variations of leptin, ghrelin and obestatin blood con-
centrations [49] thus correction of obesity implies changes
of adipokines supposed to influence allergic inflammation.
The epidemic of childhood allergic disorders has been
associated to the decline of infectious disease. However,
exposure to many triggers (airborne viruses, tobacco
smoke, pollution, indoor allergens, etc.) contribute to
the disease. Breast feeding practices, nutrition, dietary
and obesity also play a multifaceted role in shaping
the observed worldwide trends of childhood allergies.
A smaller study among Italian children has shown that
the female gender is a risk factor for asthma associated
to obesity [50]. Regular physical exercise may even
induce beneficial immune system responses and reduce
pro-inflammatory cytokines secretion [51]. In this re-
spect, the positive influence of sport on asthma encour-
ages physical activity in asthmatic children who are
obese or overweight [51]. Nevertheless, physical can play
a role on FEIA and anaphylaxis [52], hence only physical
activities that are well tolerated should be promoted in
at risk asthmatic patients.
The impact of nutrition on the development of re-
spiratory disorders in childhood may begin already be-
fore birth. In a Finnish population-based birth cohort
study (n = 2441), mother’s reduced intake of certain
foods (leafy vegetables, malaceous fruits, certain fatty
acids and chocolate) during pregnancy was associated
with increased risk of wheeze (but not asthma) in her
child at 5 years of age [53,54]. However, ‘Western-Diet”
including a higher intake of meat, eggs, vegetables’ oil
and white vegetables was linked to a reduce risk of
wheezing among children aged 16–24 Months [55]. The
intake of vitamin D is also increasingly investigated in
this area. In an experimental mouse model, vitamin D
deficiency in utero was found associated with enhanced
allergen-induced lymphocyte responses and cytokine
production into airways [56]. A case–control study of
children with severe therapy-resistant asthma, moderate
asthma and healthy controls demonstrated that patients
with severe therapy-resistant asthma have significantly
lower levels of vitamin D. Decreased levels were also as-
sociated with increased airways smooth muscle mass,
worse asthma control and lung function [57]. Vitamin D
levels may also explain seasonal variations in food aller-
gies risk [15]. Moreover, nutritional deficits have been
linked to food allergies [9,58] and supplementary nutri-
ents have been proposed. A recent case–control study
on 191 French children (mean age 4 yrs) showed that
food allergic patients are smaller than healthy controls
[59]. On the other hand, extensive nutrition restrictions
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should be established on a case by case fashion, as dem-
onstrated by a recent study on 145 British peanut aller-
gic children [60]. Last but not least, the impact of
breastfeeding on asthma and food allergy still remains a
hotly debated topic. A longitudinal study on 882 Australian
and Swedish children with parental wheeze or asthma
found a lower risk for developing asthma at age 4 and 8 yrs
among breast-fed, compared to bottle-fed children. Fur-
thermore, breast-feeding did not influence the sensitization
rate to airborne allergens but it was a risk factor for
sensitization to cow’s milk, peanuts and eggs [61]. Simi-
larly, prolonged breastfeeding and delayed introduction of
solid food provided no evidence to be protective from
atopic eczema in a population of over 18,700 Taiwan
infants [62].
Prediction and prevention
Suitable and reliable prediction tools are essential to iden-
tify targets for prevention. Since many years clinical scien-
tists are trying to find markers predicting asthma. A recent
study has shown that inflammatory markers, including
many interleukins (IL-2, IL-4, IL-8 and IL-10) are elevated
in the exhaled breath condensate already during the pre-
clinical phase anticipating wheezing [63]. Furthermore,
perinatal factors may affect lung maturity and contribute to
cause wheezing and asthma. Neonatal jaundice, for ex-
ample, increased the risk of asthma in the first six years of
life among Taiwanese neonates [64]. Atopic sensitization in
infancy has been often used as a predictor of atopic diseases
at school age. Recently, Item Response Theory (IRT)
models, have been applied to SPT results at 2 years of age
to predict persistent wheeze, rhino-conjunctivitis, and ec-
zema at age 4 and to identify the allergens most associated
with atopy predisposition [65].
Prediction models are used to facilitate the identifica-
tion of targets for prevention. Until a few years ago,
allergic asthma prevention has been mostly based on al-
lergen avoidance. Studies results though show no or lit-
tle benefit from allergen avoidance. By contrast, a
national plan for allergy and asthma prevention, recently
implemented in Finland, has shown that implementation
of balanced diets, physical activity and protection from
other allergy promoting factors such as tobacco smoke
represent adequate prevention methods [66]. This Finnish
program was then based on a multifaceted strategy. The
complexity of the immune response and of allergy patho-
genesis is making more and more questionable if one kind
of intervention alone is sufficient to prevent allergic dis-
ease in high risk children. More and more relevance is
being given to the concept of a poly-factorial intervention,
based on both, avoiding risk factors and providing protect-
ive factors. Unfortunately, the feasibility of interventions
in everyday life declines with their increasing complexity[66-68]. For example, a study on 476 Dutch children dem-
onstrated that PREVASC multifaceted intervention was
efficient in reducing the exposure to inhalant and food al-
lergens. Nevertheless, this program was unable to reduce
the prevalence of asthma at the age of 6 yrs, as the parents
were unable to properly implement all the measures of
this complex prevention plan [69].
In contrast to asthma, studies on prediction and preven-
tion of atopic eczema are still providing relatively conflict-
ing outcomes. However, the “classical” biomarkers of
allergy, such as total and specific IgE levels are still consid-
ered valuable pre-clinical predictive biomarkers [70-73].
For example, elevated maternal IgE levels during preg-
nancy were associated in non-atopic mothers to increased
risk of eczema in offspring [70]. Elevated cord blood IgE,
together with specific LT-α and FcεRI-β genotypes and a
higher maternal stress during pregnancy were linked to a
higher risk of eczema at age of 2 yrs [71]. Similarly, not
SPT [72] but IgE levels can be useful in predicting a posi-
tive food challenge test [73]. Although these biomarkers
can help predicting atopic eczema [74], prevention is un-
fortunately still difficult. Probiotics are widely marketed as
useful against food allergy [75,76], respiratory infections
[77] and airway inflammation [78], but their preventive ef-
ficacy has not been confirmed. For example, Lactobacillus
rhamnosus GG, given to the mother during pregnancy,
had no influence on her child’s gut colonization profile
[79] and their content in cow’s milk and egg’s white pro-
teins may be even dangerous for allergic patients [80].
However, supplementation of the probiotic Lactobacillus
plantarum CJLP133 provided beneficial results in the
treatment of pediatric AD in a case–control study on 88
Korean children between 12 months and 13 yrs [81].
Monitoring and control
Asthma control is essential to prevent long-term conse-
quences of asthma and improve patients’ quality of life.
Hence, many studies focus on identification of reliable
diagnostic tools to monitor asthma control. While the
diagnostic role of atopic tests, lung function and chal-
lenge tests in asthma are quite established since decades
that of breath condensate is still hotly debated. Exhaled
nitric oxide (NO), a non-invasive marker of airway in-
flammation, can be implemented in the diagnosis and
management of asthma and its strong relation to atopy,
(e.g. house dust mite sensitization) has been recently de-
scribed [82]. Furthermore, elevated bronchial NO output is
associated with an increased risk of exercise-induced
bronchoconstriction in atopic patients during childhood
and adolescence [51]. Similarly, fractional exhaled NO
(FeNO) was also elevated in the sputum of asthmatics with
coexisting food allergy suggesting an association of asthma
with food allergies through an increased eosinophilic in-
flammation [83]. Accordingly, in 467 children from the
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was only elevated in asthmatic patient with simultaneous
sensitization to food and pollen allergens [84]. Unfortu-
nately, FeNO levels in exhaled breath may be not always
appropriate as a marker to monitor asthma control over
time [85]. This has been also confirmed by a study showing
a poor accuracy to discriminate well- from not well-
controlled asthma in a case–control study among 664
Dutch children aged 4–12 yrs [86].
Other measures of oxidative stress have been also tested.
A case–control study on 219 Turkish children has shown
that higher concentrations of Malondialdehyde and GSH
in exhaled breath condensate are a marker of asthma and
allergic rhinitis and are associated with enhanced oxidative
stress [87]. Another case–control study among 22 asth-
matic Swedish children (6–18 years) demonstrated the
relevance of basophil allergen threshold sensitivity (also
CD-sens) in identifying those with the most severe and
uncontrolled allergic asthma [88]. Last, clinical indexes are
also intensively investigated, as they can allow daily moni-
toring. The visual analogue scale (VAS), a widespread
assessment in Pediatrics, confirmed its usefulness in meas-
uring breathlessness perception in Italian asthmatic chil-
dren and was significantly related to lung function [89].
However, other clinic assessments lack so far of unsatisfy-
ing accuracy and reliability levels. A study in 314 patients
has recently shown that both, GINA-guided and C-ACT-
guided (Childhood-Asthma Control Test) assessment have
a poor accuracy and reliability in measuring the level of
asthma control, if used separately [90].
Anti-inflammatory drugs and bronchodilators [91-93]
and antibiotics (e.g. macrolides) [94] help controlling
asthma but allergen-specific immunotherapy (SIT) is the
only treatment potentially changing the natural history
of the allergic component of moderate asthma, with a
potential long lasting exacerbation-preventing effect and
corticosteroid-sparing effect [95]. However, due to the
difficulty in carrying out placebo controlled trials, effi-
cacy of SIT, especially in its subcutaneous version
(SCIT), has been so far demonstrated in children by a
few trials only [96-98].
Food allergy monitoring and control is a highly devel-
oping area of investigation and we can consider here
only a few examples of studies dealing with the need of
molecular diagnosis, the antigen-specificity of oral toler-
ance induction and the use of epinephrine, respectively.
Cross-reactivity and pan-allergens represent one of the
difficulties that often hamper the diagnosis of allergies to
vegetal food in childhood. Therefore, diagnostic tools
should be developed to support clinicians in distinguish-
ing between tolerant and allergic and then between
primary and secondary allergic patients. In birch-pollen-
associated secondary soy allergy, SPT with soy flour and
molecular diagnostic of specific IgE to Gly m4 facilitate acorrect diagnosis [99]. IgE levels to seed storage proteins
Ara h1, Ara h2 and Ara h3 allow distinguishing peanut-
allergic from tolerant patients [100,101]. By contrast,
peanut-specific IgG or IgG4 levels were elevated in
peanut-sensitized children and did not indicate tolerance
or protection from sensitization as observed in other
atopic diseases [102]. Similar findings were also shown in
patients with egg allergy, where elevated levels of specific
IgG to ovalbumin, β-lactoglobulin and α-casein were asso-
ciated with positive SPT to egg. In contrary, elevated IgG4
levels to α-casein was linked to a negative DBPC cow’s
milk challenge [103]. On the other hand, cytokines and
other immunological markers are being investigated for a
more precise monitoring of food allergies. For example,
the interleukin IL-21 may be involved in the pathogenesis
of atopic dermatitis [104] and the chemokine CCL18, also
known as pulmonary and activation-regulated chemokine
(PARC), may be linked to disease severity [105].
Studies on oral tolerance induction (OIT) are defining
more and more the usefulness and limitations of this
novel therapeutic approach. Cow’s milk allergy affects
1.9-4.9% of the children, of which a few might suffer
from a protein energy malnutrition caused by the subse-
quent dietary [106]. Therefore, oral tolerance induction
provides a chance for these patients to avoid possible
late-implication caused by dietary restrictions such as
growth impairment. Recent studies on SOTI demon-
strated an increase of regulatory cells such as Foxp3+
regulatory T-cells and other hypo-proliferative subset of
T-cells (CD4+, CD38+ and CD45RO-) which characterize
tolerance development, suggesting possible pathways for
tolerance induction in cow’s milk and hen’s egg allergic pa-
tients [107,108]. The induction of clinical tolerance, how-
ever, is antigen specific. This aspect is essential from a
clinical stand point, as many children with cow’s milk al-
lergy react also to goat’s or sheep’s milk. Unfortunately, or-
ally induced tolerance to cow’s milk does not protect these
children from reactions to the milk of other mammals
[109,110] and elimination diets are sometime not suffi-
cient to avoid severe reactions in allergic children [111]. A
few children with severe food allergies cannot be treated
with SOTI, as they do not tolerate even minute amount of
the relevant allergen. In these children, proper education,
availability and correct use of epinephrine is often essen-
tial. Unfortunately this is not always the case. A recent
investigation of 1361 adverse reactions to food in the US
showed that only one third of the reactions requiring inter-
vention with epinephrine were correctly managed [58].
Actually, guidelines on anaphylaxis are not sufficiently im-
plemented although they are distributed to most pediatri-
cians [112]. Education and awareness about anaphylaxis is
therefore still insufficient to guarantee guidelines imple-
mentation and the guidelines themselves should be perhaps
simplified and made more user-friendly [113].
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Despite intensive research and progress, allergic diseases
in childhood still represent a complex challenge for the
family and the society. They has a considerable impact
on quality of life for the patients and a financial burden
for the society caused by increased costs, morbidity and
mortality [114]. A recent meta-analysis considering al-
most 3550 children with asthma has shown that patients
suffer from more depression and anxiety, independently
from the level of severity of their asthma [115]. Similarly,
among the asthmatic adults screened in the Asthma
Insight and Management (AIM) survey in the United
States, patients rated their health as “only fair,” “poor,”
or “very poor,” or experienced limitations in activity be-
cause of health problems, compared with the general
population. This indicates that the burden of asthma re-
mains high in the US despite the availability of updated
treatment guidelines and new therapies [116]. Moreover,
severe reactions observed in food allergies have also im-
mense impact on patients’ quality of life. A recent survey
on the life quality of food allergic children showed that
patients who experienced severe systemic reactions, with
multiple food allergies or with siblings/mother affected
by allergies score worse in quality of life questionnaire
[117]. In this respect, it is interesting to note that a farm-
ing environment, which in somehow implies a healthier
contact with nature, can influence not only physical and
objective reactions but also the psychological well-being of
allergic and asthmatic patients [118].
Hence, not only for the patients, but also for their
families it is important to establish clear plans beyond the
patient’s direct needs by involving the community. Such
perspectives can be successfully achieved by national-
wide management programs aimed at minimizing dis-
ease’s impact on the whole society and the healthcare
systems [66]. Further inputs provided by parents and/or
patients associations might be useful. A management
curriculum for the parents of newly diagnosed food
allergic children can reduce both stress and anxiety and
improve the quality of life of the allergic children and
their parents [119].
Guidelines for treatment are available, but their
implementation is suboptimal. Developed countries
are slowing learning integrating the development of
suitable guidelines with implementation plans.
Awareness, psychosocial and family factors strongly
influence asthma and food allergy control. Moreover,
monitoring tools are necessary to facilitate self-
management. By taking into consideration these and
many other pragmatic aspects, national public health
programs to control the allergic epidemic have been
successful in reducing its impact and trace the need
for future research in the area.Moreover, awareness for food allergies and anaphylaxis
must be improved also among teachers and school-
personnel, since schools are the places with the highest
attack-related death rate [120]. Recommendations must not
only guide diagnosis and treatment, but should also prevent
unjustified and exaggerated allergen avoidance, which heav-
ily affect life quality and immunologic tolerance develop-
ment. This is true not only for food, but also for respiratory
allergies. Accordingly, asthma control programs have to be
made easy and integrated into everyday life. An authentic
reflection of the difficulties facing implementation of
asthma control programs in real life has been shown by the
results of the CHOICE survey on 1000 American asthmatic
patients. Almost the half of the patients did not use con-
troller medications while 80% of those had a persistent
asthma. Moreover, only 14.3% of patients on controllers
were well controlled [121]. Other studies reported high
levels of over- and under-treatment for asthma [122,123].
Hence, despite updated guidelines, the large offer in medi-
cation and active national management programs, control
programs are still not well implemented in “real life”. Old
guidelines included also unnecessary recommendations: for
example, pet avoidance has been a long-lasting prescription
for asthma prevention. Recent studies have confirmed that
pet exposure in early life is not to be suspended even in
families with “at risk” atopic/allergic children, unless pet
already cause symptoms [124]. Guidelines should be
therefore “user friendly”, so that GPs, parents, health
care centers and schools can easily learn how to handle
asthma without useless restriction or even harming in-
fluences for the affected children. This has been con-
firmed by a recent study on 170 Dutch children, where
parental concerns about adverse consequences of the
medication and low maternal education were associated
with uncontrolled asthma [125]. Attention to guidelines
feasibility has probably greatly contributed to the suc-
cess of the Finnish plan for asthma control [66]. The
Finnish experience can therefore encourage other coun-
tries to in their attempt to revert the epidemic trend of
asthma and allergies or at least to control better the so-
cial impact of this childhood chronic disease.
Conclusion
The most recent advances in the field of childhood asthma
summarized in this review give us an idea of how fast
clinical research in this area is making progress. Solid ap-
proaches to avoid risk factors and to promote protective
factors should be established according to the recent find-
ings. Nevertheless, many studies demonstrated the huge
lack in adopting and implementing recommendations and
guidelines in everyday life, which require further develop-
ment of current intervention and control strategies in the
framework of national asthma control programs to choke
the worldwide asthma epidemic.
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